PX‐478 displayed better tumour vascular suppression than BPR0C261 using NIR‐II‐emitted Pdots, and this result was consistent with the responses of VEGF expression in tumours distinctly treated with these compounds. This evidence concerns the gene VEGFA and neoplasm.